Liminal Biosciences Inc. (LMNL) Social Stream



Liminal Biosciences Inc. (LMNL): $1.10

-0.02 (-1.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LMNL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Liminal BioSciences Inc (LMNL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering LMNL.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $4.5 $2.3 $3.1 $1.09 184.4%

The Trend in the Analyst Price Target


LMNL's average price target has moved up $0.05 over the prior 53 days.

Over the past 41 weeks, LMNL's average upside potential has been 74.99%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 4 4.49836 2.29916 3.60037 2.52 42.87%
2021-09-20 4 4.55875 2.33003 3.64870 2.52 44.79%
2021-09-20 4 4.59382 2.34795 3.67677 2.52 45.9%
2021-09-20 4 4.59672 2.34943 3.67909 2.52 46%
2021-09-20 4 4.60909 2.35576 3.68899 2.52 46.39%
2021-09-20 4 4.59270 2.34738 3.67588 2.52 45.87%
2021-05-27 4 22.09544 2.81215 9.99288 4.23 136.24%
2021-05-27 4 21.94338 2.79279 9.92411 4.23 134.61%
2021-05-27 4 21.70496 2.76245 9.81628 4.23 132.06%
2021-05-27 4 21.65459 2.75604 9.79350 4.23 131.52%
2021-05-27 4 21.43579 2.72819 9.69455 4.23 129.19%
2021-05-27 4 21.15995 2.69308 9.56980 4.23 126.24%
2021-05-27 4 21.23538 2.70268 9.60391 4.23 127.04%
2020-12-09 0 16.49348 4.63879 10.56538 NA NA%
2020-12-09 2 16.49348 4.63879 10.56538 NA NA%
2020-12-09 0 20.66880 5.81310 13.24000 NA NA%
2020-12-09 2 20.66880 5.81310 13.24000 NA NA%
2020-12-09 0 16.47350 4.63317 10.55258 NA NA%
2020-12-09 2 16.47350 4.63317 10.55258 NA NA%

LMNL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.5 0 0 3 1 1 4

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Liminal BioSciences Inc's average analyst price target is higher than 1.29% of all US stocks.
  • In terms of how Liminal BioSciences Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than 16.24% of that group.
  • Liminal BioSciences Inc's number of analysts covering the stock is higher than 25.49% of Pharmaceutical Products stocks.
  • In the context of stocks in the small market cap category, Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is higher than 73.85% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Liminal BioSciences Inc are APRE, AVIR and ADAP.

Make investment decisions regarding LMNL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8189 seconds.